Can PPARγ Ligands Be Used in Cancer Therapy?
Maria Grazia Rumi(University of Milan), Yuta Kinoshita(Shimane University), Yasunori Kadowaki(Shimane University), Shunji Ishihara(Shimane University), Hideaki Kazumori(Shimane University)
Cited by 57
Related Papers
Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response.
|Journal of Clinical Investigation|1996|661
A morphometric and immunohistochemical study to assess the benefit of a sustained virological response in hepatitis C virus patients with cirrhosis
|Hepatology|2012|405
High rates of 30-day mortality in patients with cirrhosis and COVID-19
|Journal of Hepatology|2020|394